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Abstract
Background: The clinical syndrome associated with secondary syphilis (SS) reflects the propensity of Treponema pallidum
(Tp) to escape immune recognition while simultaneously inducing inflammation.
Methods: To better understand the duality of immune evasion and immune recognition in human syphilis, herein we used a
combination of flow cytometry, immunohistochemistry (IHC), and transcriptional profiling to study the immune response in
the blood and skin of 27 HIV(-) SS patients in relation to spirochetal burdens. Ex vivo opsonophagocytosis assays using
human syphilitic sera (HSS) were performed to model spirochete-monocyte/macrophage interactions in vivo.
Results: Despite the presence of low-level spirochetemia, as well as immunophenotypic changes suggestive of monocyte
activation, we did not detect systemic cytokine production. SS subjects had substantial decreases in circulating DCs and in
IFNc-producing and cytotoxic NK-cells, along with an emergent CD562/CD16+ NK-cell subset in blood. Skin lesions, which
had visible Tp by IHC and substantial amounts of Tp-DNA, had large numbers of macrophages (CD68+), a relative increase in
CD8+ T-cells over CD4+ T-cells and were enriched for CD56+ NK-cells. Skin lesions contained transcripts for cytokines (IFN-c,
TNF-a), chemokines (CCL2, CXCL10), macrophage and DC activation markers (CD40, CD86), Fc-mediated phagocytosis
receptors (FccRI, FccR3), IFN-b and effector molecules associated with CD8 and NK-cell cytotoxic responses. While HSS
promoted uptake of Tp in conjunction with monocyte activation, most spirochetes were not internalized.
Conclusions: Our findings support the importance of macrophage driven opsonophagocytosis and cell mediated immunity
in treponemal clearance, while suggesting that the balance between phagocytic uptake and evasion is influenced by the
relative burdens of bacteria in blood and skin and the presence of Tp subpopulations with differential capacities for binding
opsonic antibodies. They also bring to light the extent of the systemic innate and adaptive immunologic abnormalities that
define the secondary stage of the disease, which in the skin of patients trends towards a T-cell cytolytic response.
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Introduction
Syphilis is a sexually transmitted multi-stage disease caused by
the spirochetal bacterium Treponema pallidum (Tp), subspecies
pallidum [1,2]. Despite the existence of inexpensive and effective
antibiotic treatment regimens, more than 10.5 million new syphilis
cases are estimated to occur yearly throughout the world [3].
Infection begins when the bacterium comes into contact with skin
or mucous membranes, multiplying locally, while simultaneously
disseminating through blood vessels and lymphatics [1,2,4–6]. The
distinctive painless ulcer (chancre) of primary syphilis typically
appears 2–4 weeks after the initial contact with the spirochete
[2,6,7]. By this time, organisms that have disseminated from the
primary site of infection have invaded various organ tissues, most
notably the skin [2,6], setting the stage for what is classically
known as secondary syphilis (SS). SS, the principal focus of the
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current study, characteristically presents with a variety of muco-
cutaneous manifestations as well as systemic signs and symptoms
within 4–10 weeks of the initial infection [4,5,8]. Despite the
robust nature of the cellular and humoral immune responses
associated with SS, weeks to months may elapse before lesions
resolve. Infectious relapses are common during the first few years
of infection [2], while approximately one-third of untreated
patients develop one of the potentially devastating forms of
recrudescent disease collectively referred as tertiary syphilis [9].
The factors that influence the complex and shifting balance
between this persistent bacterium and host clearance mechanisms
are not well understood.
T. pallidum contains abundant lipoproteins which are capable of
activating macrophages and DCs via CD14 [10–13] and Toll-like
receptor 1 (TLR1) and TLR2-dependent signaling pathways
[11,12,14–16]; consequently, these pathogen associated molecular
patterns (PAMPs) are believed to be major pro-inflammatory
agonists during spirochetal infection [17]. However, due to the
bacterium’s unique outer membrane (OM) structure, which
includes a lack of surface exposed lipoproteins [18–22], these
PAMPs are not readily accessible to TLRs or other pattern
recognition receptors (PRRs) present on monocytes/macrophages
or dendritic cells (DCs). As a result, it is believed that spirochetes
can replicate in tissues and disseminate without triggering innate
pathogen recognition systems. Presumably, as local spirochetal
burdens increase, a small number of organisms are taken up by
tissue-based DCs; which then traffic to draining lymph nodes to
present cognate treponemal antigens to naı¨ve T and B-cells. The
emergence of opsonic antibodies would then enhance uptake and
degradation of the bacterium in tissues, allowing spirochetal
PAMPs to gain access to PRRs lining the phagocytic vacuole and
triggering their activation [23]. Because of the bacterium’s
extraordinarily low density of integral outer membrane proteins
(OMPs) [1,19,24,25] and the limited antibody responses they elicit
in humans [24–26], anti-treponemal antibodies alone are unlikely
to be sufficient to control bacterial replication and prevent further
dissemination. In support of this idea, ex vivo opsonophagocytosis
assays using either rabbit peritoneal macrophages [27] or human
PBMCs [28] point out that even in the presence of syphilis
immune sera, substantial numbers of spirochetes avoid phagocy-
tosis. Lastly, findings from a recent study provide additional
evidence that organisms within Tp populations differ widely with
respect to the density of surface antigens recognized by syphilitic
sera [25].
T. pallidum is capable of provoking an intense cellular immune
response generally believed to be the cause of the tissue damage
that gives rise to clinical manifestations [5]. The extent to which
the diverse cellular components of syphilitic infiltrates contribute
to clearance of spirochetes, however, remains an open question. In
the rabbit model, the appearance of Tp reactive lymphocytes
correlates with the progression of mononuclear cell infiltration and
macrophage activation at the sites of experimental inoculation
[29–31]. Immunohistochemistry (IHC) and RT-PCR analysis of
biopsy specimens obtained from patients with primary and
secondary syphilis lesions demonstrate that syphilitic skin lesions
are also composed of lymphocytes and macrophages capable of
expressing mRNA for the Th1 cytokines, IL-2, IFNc and IL-12
[32,33]. While helper T-cells outnumber cytolytic T-cells in
experimentally infected rabbit tissues [34] and in human primary
syphilitic lesions [35], equal or greater numbers of CD8+ T-cells
characterize human SS syphilis inflammatory infiltrates [35–38].
The finding by Van Voorhis et al [32] that both perforin and
granzyme B are expressed in human syphilis lesions supports the
idea that in Tp-infected SS skin tissues cytolytic T-cells have a role
in bacterial clearance. How CD8+ T-cells are activated in the skin
is unclear given that this lymphocyte subset usually responds to
antigens presented via the class I Major Histocompatibility
Complex (MHC) pathway [39], which is generally not associated
with control of extracellular pathogens like Tp.
Efforts to understand the duality of immune evasion and
immune recognition in syphilis have been hindered by the inability
to propagate the bacterium in vitro and the lack of a suitable inbred
animal model for performing immunologic studies. To circumvent
these problems and obtain information directly relevant to the
disease process in humans, we have been studying SS, the stage in
which the dichotomous features of syphilitic infection are clearly
evident and specimens are readily obtainable. Herein, we used a
combination of flow cytometry, IHC and transcriptional profiling
to investigate key aspects of the innate and adaptive immune
response in the blood and skin of untreated SS patients in relation
to the spirochetal burdens present in each of these two
immunologically distinct compartments. We then used our
previously described ex vivo opsonophagocytosis assay [28,40] to
model spirochete-monocyte/macrophage interactions in the blood
and skin. As a whole, our findings support the importance of
opsonophagocytosis as a primary means for clearance of
treponemes, while suggesting that the balance between phagocytic
uptake and evasion is determined by the relative burdens of
bacteria and the presence of Tp subpopulations with differential
capacities for binding opsonic antibodies. The findings in the skin
demonstrate that in addition to CD4+ and CD8+ T-cells, CD56+
NK-cells are also enriched and are thus likely to participate in
activation of dermal macrophages through their ability to secrete
IFN-c. Unexpectedly, we discovered that patients have profound
immunophenotypic alterations in circulating monocytes, DCs and
NK-cells, including the emergence of a CD56negativeCD16high NK-
cell subset that is known to be highly dysfunctional in patients with
uncontrolled chronic viral infections [41,42]. These findings reveal
the extent of the systemic innate and adaptive immunologic
abnormalities that define the secondary stage of the disease, which
in the skin of patients trends towards a T-cell cytolytic response.
Author Summary
Syphilis, a sexually transmitted disease caused by the
spirochetal bacterium Treponema pallidum, affects close to
10 million people per year worldwide. Despite the robust
nature of the humoral and cellular immune responses
associated with the disease, weeks to months may elapse
before the host gains control of the infection. Moreover, in
the absence of antibiotic treatment, containment is often
incomplete and relapses are common. Herein we studied
aspects of the immune response in the blood and skin of
patients with secondary syphilis to better understand the
factors that determine whether the bacterium evades host
defenses or is cleared in its natural human host. Our
findings support the importance of the macrophage as a
primary means of bacterial killing in the skin, while
suggesting that the extent of bacterial clearance is
determined by the bacterial loads present in either the
blood or skin of patients and the appearance of
spirochetes which are resistant to uptake (phagocytosis)
by the macrophages. Study results underscore the extent
of the systemic immunologic abnormalities triggered by
the bacterium and provide new insights regarding the
complexity of the immune response in the skin of
untreated patients.
Innate and Adaptive Immunity in Secondary Syphilis
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Materials and Methods
Human Subjects
Adult SS patients were identified and referred for enrollment
through a previously described network of health care profession-
als in Cali, Colombia [8]. The diagnosis of SS was based on the
medical history and compatible skin or mucosal lesions, reactive
non-treponemal test (RPR, Rapid Plasma Reagin titer$1:8) and a
positive confirmatory treponemal test (FTA-ABS, Fluorescent
Treponemal Antibody Test Absorbed). All serological tests were
performed at a reference laboratory in Colombia (Clı´nica
Colsanitas). Patients were excluded if they were known to be
HIV-positive, if they had serologic evidence of current or prior
infection with hepatitis B or hepatitis C, were receiving anti-
inflammatory or immunosuppressive medications, had recently
used antibiotics, or had a history of chronic dermatitis or other
underlying acute or chronic disease. Peripheral whole blood
samples obtained from enrolled patients, along with 4-mm punch
skin biopsies from secondary syphilis lesions from a subset of these
patients, were processed for immunological and molecular assays
as described below. All patients were treated with 2.4 million units
of intramuscular benzathine penicillin as recommended by
Colombian public health standards, which are in accord with
available CDC treatment guidelines. Patients were asked to return
two months after receiving antibiotic treatment for a clinical and
immunological follow-up. Healthy control volunteers (non-reactive
RPR, negative FTA-ABS, non-HIV/HBV/HCV), of similar
background and socio-economic status, were recruited by the
study site in Cali. Healthy volunteers, with no serologic evidence of
prior or current syphilis, were recruited at the University of
Connecticut Health Center (UCHC) to serve as controls for the ex
vivo Tp-monocyte stimulation experiments (described below). The
Institutional Review Boards of, Centro Internacional de Entrena-
miento e Investigaciones Me´dicas (CIDEIM) in Cali, Colombia,
the Connecticut Children’s Medical Center (CCMC), UCHC and
the Center for Diseases Control and Prevention (CDC) approved
all relevant study protocols. All healthy volunteer and syphilis
patients, regardless of whether they were enrolled by the Cali site
or at UCHC, gave voluntary written informed consent to
participate in the study.
A total of 27 HIV-negative SS patients were eligible for
participation. Clinical and epidemiologic features for these
patients are summarized in Table 1. Peripheral blood mononu-
clear cells (PBMCs) obtained from whole blood samples from these
patients were examined by flow cytometry and RT-PCR at the
time of enrollment as described below. Flow cytometric analysis
was repeated in a subset (n = 13) of enrolled SS patients
approximately 60 days after receiving antibiotic treatment. A
total of 12 of the 27 SS patients also had skin biopsies processed for
targeted array analysis (12/12); skin biopsies were also studied by
IHC in four of the twelve patients. We previously reported
quantitative Tp DNA results from whole blood samples obtained
from all 27 SS patients studied herein [8]. In the current study we
also determined spirochetal burdens in 4 SS skin lesion samples
from these same patients and that also were studied by IHC. A
total of 26 healthy volunteers were enrolled at the Cali site; 23
controls were included for flow cytometric immunologic studies
and three additional subjects provided healthy skin control
samples for microarray analysis (see below).
Propagation and Harvesting of T. pallidum
Live Tp (Nichols strain) was used for the monocyte simulation
experiments on the same day of the extraction from rabbit testicles
as previously described [28]. All animal experimentation was
conducted following the NIH guidelines for housing and care of
laboratory animals and was performed in accordance with the
UCHC institutional regulations after review and approval by
Institutional Animal Care and Use Committee.
Monocyte Isolation and Stimulation
Highly purified human monocytes were isolated from healthy
volunteer PBMCs using a magnetic cell sorting monocyte
isolation kit (Miltenyi Biotech, Auburnas) as previously described
[17]. Cells were plated and incubated with 10% heat inactivated
normal human sera (NHS) or human syphilitic sera (HSS) for 8-
hours at 37uC/5% CO2 with fresh Tp at multiplicities of infection
(MOIs) of 1, 10 and 30. In some assays, 100 ng/ml of LPS
(Sigma-Aldrich) was used as a positive control for cytokine
production. At the end of the 8-hr incubation period, cells were
harvested for flow cytometry, epifluorescence and confocal
Table 1. Clinical and laboratory characteristics of secondary
syphilis patients.
(n = 27)
Gender
Male 8 (30%)
Female 19 (70%)
Age
Age, mean (range), years 36(19–64)
Race
White 0
Mestizo 20 (74%)
Black 7 (26%)
Clinical Findings
Duration of skin rash, mean (range), days 40 (7–120)
Skin lesions
Plaques on palms and/or soles 19 (70%)
Moth eaten alopecia 1 (4%)
Codylomata lata 5 (19%)
Mucosal lesions 8 (30%)
Mild flu-like symptoms (i.e. headache, myalgias) 20 (74%)
Adenopathy 13 (48%)
Laboratory Findings
RPR titer
.1:64 21 (78%)
.1:16 but ,1:64 5 (19%)
.1:8 but ,1:16 1 (4%)
Erythrosedimentation rate (ESR) .15 18 (67%)
Lymphopenia (,30%) 12 (44%)
Anemia (Hgb ,12) 8 (30%)
polA+PCR *
Peripheral Blood
Positive total samples studied (n = 25) 12/25 (44%)
Positive when DNA extracted fresh (n = 11) 7/11 (66%)
Tp polA copies: monocyte ratio (‘‘MOI’’) 0.3–0.9:1
Secondary syphilis skin lesions
Positive (n = 12) 8/12 (67%)
*Diagnostic PCR results previously published in PLoS NTD (Ref 8).
doi:10.1371/journal.pntd.0001717.t001
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microscopy. Supernatants were collected for cytokine analysis
and Tp counting. Experiments with HSS were performed using a
pool of sera from a group of HIV-seronegative SS patients as
previously reported [28]. All culture media and reagents utilized
in the stimulation experiments were confirmed to be free of LPS
contamination (,10 pg/ml) by Limulus amoebocyte lysate assay
quantification (Cambrex, MA).
Cell staining and Flow Cytometry
Isolated monocytes from healthy US volunteers and PBMCs
from SS syphilis patients and controls, where processed for flow
cytometry as previously described [43]. The antibody panels used
in for flow cytometry are listed in Table 2. Surface staining
procedures were done as previously described [28]. Individual cell
populations were selectively gated for analysis based on the
expression of corresponding immuno-phenotypes. Multiparameter
files were analyzed using WINMDI v2.8 software (Joseph Trotter,
Scripps Clinic).
Opsonization Assays
Human PBMCs obtained from healthy US volunteers were
plated and stimulated with freshly extracted Tp Nichols strain at
37uC/5% CO2. Selected samples were incubated with 10% heat
inactivated (56uC for 30 min) NHS or with 10% heat inactivated
HSS obtained from individual SS patients or pooled samples from
Cali SS patients. Samples were incubated in the presence of
LysoTracker Red endosomal dye (Molecular Probes), and
harvested after a 4-hr incubation period. Tp–cell associations
were visualized by immunofluorescence assay (IFA) as previously
described [28]. Images were acquired on an Olympus BX41
epifluorescence microscope equipped with a Retiga Exi CCD
camera (QImaging) and processed with ImageJ 1.40 (NIH, USA).
To quantitate spirochetal uptake, up to 10 fields were selected
sequentially and monocytes containing internalized and degraded
spirochetes in the form of fluorescent blebs were counted using
images acquired by epifluorescence microscopy. A total of 100
cells were counted for isolated monocyte experiments. After an 8-
hr incubation period 10 ml aliquots from Tp-stimulated-monocyte
supernatants were enumerated, in triplicate, by dark-field micros-
copy on a Petroff-Hausser counting chamber. Percentage of
bacterial recovery was calculated using a ‘‘time zero’’ spirochetal
count.
Serum and Ex-Vivo Stimulation Supernatant Cytokine
Analysis
Simultaneous measurements of TNF-a, IL1-b, IL-6 and IL-10
were performed in supernatants from ex vivo experiments and in
individual SS patient’s serum, using a Human Inflammatory
Cytokine Bead Array (CBA) per the manufacturer’s (BD) protocol.
Quantitative Real Time Reverse Transcriptase PCR (qRT-
PCR)
Isolated PBMCs (26106 cells) from SS patients and healthy
controls were stored in 300 ml of RNA later at 280uC until
processing. RNA was extracted at the Cali site using the RNeasy
Mini Kit (Qiagen) according to the manufacturer’s protocol. Up-
or down-regulation of selected transcripts were measured in
Complementary DNA (cDNA) from ex vivo Tp-monocyte stimu-
lation experiments for selected genes by quantitative RT-PCR
(qRT-PCR) analyses. RNA was extracted from both stimulated
and unstimulated cells using the Paxgene blood RNA kit (Qiagen,
Valencia, CA). The quality of the RNA was verified both with the
DU 530 Life Science spectrophotometer (Beckman, Fullerton, CA)
and Agillent Bioanalyzer. cDNA was prepared from both patient
and healthy donor extracted RNA samples using a high capacity
cDNA RT kit. (Qiagen, Foster City, CA). Commercially available
gene expression assays (Applied Biosystems) were used for
amplification of the following transcripts; TNF-a (Hs00174128
_m1), IL-1b (Hs00174097_m1), IL-6 (Hs00985639_m1), IL10
(Hs00174086_m1Hs), IFN-b (Hs00277188_s1), TLR2
(Hs00610101_m1), TLR7 (Hs00152971_m1), TLR8 (Hs00152972
_m1), TLR9 (Hs00152973_m1), CD40 (Hs00374176_m1), IL-17
(Hs99999082_m1) and IFN-c (Hs00174143_m1). qRT-PCR gene
expression assays for the house keeping gene, glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) (Hs99999905_m1), were
performed using identical aliquots of each cDNA as normalization
controls. All amplification reactions were performed in triplicate;
control reactions without reverse transcriptase also were performed
to confirm the absence of contaminating DNA. Expression levels of
all transcripts studied were normalized to the GAPDH level and the
relative changes in gene expression were calculated using the
22DDCt method [44].
DNA Extraction from SS Skin Biopsies
DNA from tissues (15–25 mg) was extracted using the QIAamp
DNA minikit (QIAGEN Inc., Valencia, CA) following procedures
recommended by the manufacturer. DNA was eluted from the
QIAGEN columns in 100 ml of elution buffer at 70uC and stored
at 280uC. The concentration of DNA was determined spectro-
photometrically by the 260/280 nm absorbance. The quality and
integrity of the DNA were determined by electrophoretic
fractionation of 5 ml of extracted DNA through 1.2% agarose
gels (E-gels: Invitrogen Corp., Carlsbad, CA) at 70 V for 30 min.
Table 2. Antibody staining panels used for flow cytometric analysis.
Experiment Panel Fluorochrome Label Immunophenotypes
FITC Phycoerythrin PerCP APC
Isolated monocytes (ex vivo experiments) 1 CD40 CD83 CD14 Activated monocytes
PBMCs (SS patients) 1 CD14 D83 isotype CD40 isotype Isotype control
2 CD14 CD83 CD40 Activated monocytes
3 Lineage cocktail CD83 isotype HLA-DR CD11c Isotype control
4 Lineage cocktail CD83 HLA-DR CD11c Activated dendritic cells (DCs)
5 CD56 CD16 CD3 NK-cells
doi:10.1371/journal.pntd.0001717.t002
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Measurement of Spirochetal Burdens by Quantitative
Real-Time PCR
PCR amplification of the Tp polA gene was performed using
forward primer TP-1 (59CAGGATCCGGCATATGTCC39), re-
verse primer TP-2 (59AAGTGTGAGCGTCTCATCATTCC39),
and probe TP-3 (59CTGTCATGCACCA GCTTCGACG-
TCTT39) as previously published [45], with some exceptions. The
probe was labeled with Cyanine (Cy5) at the 59 end and black-hole
quencher 3 (BHQ3) at the 39 end. Thermocycling was performed in
a Rotor-Gene 6000 instrument (Qiagen, Valencia, CA) as follows:
two hold cycles at 50uC for 2 min and 95uC for 10 min,
respectively; and 45 cycles of 95uC for 15 sec and 60uC for
1 min. Each PCR run included positive and negative (no template)
control reactions. The Tp copy numbers for each skin biopsy
specimen were extrapolated from the standard curve generated
using ten-fold serial dilutions of purified Tp DNA. The raw data
obtained from the amplifications were adjusted for quantity tested to
generate the polA DNA concentration, expressed as copies/ml or
copies/mg of extracted cellular DNA from tissues.
Skin Biopsy Arrays
A 4-mm punch biopsy from SS skin lesions was obtained from a
group of 12 patients and from normal skin from 3 healthy
Colombian controls (see above), snap-frozen and stored in liquid
nitrogen in preparation for overnight transportation on dry ice
from Cali to UCHC. Upon arrival at UCHC, tissues were
homogenized in Trizol (Invitrogen), RNA was isolated, cleaned
with Turbo DNase (Ambion, Applied Biosystems) followed by
cDNA synthesis using High Capacity cDNA Archive Kit (Applied
Biosystems) according to the manufactures instructions. Gene
transcripts were amplified per manufacturer’s instructions (Applied
Biosystems) using two commercially available array kits; TaqManH
Human Immune Array and TaqManH Human Phagocytosis
Array. Briefly, the array was performed in a 2 mL reaction volume
containing 62.5 pg of cDNA, 1 mL of water and 1 uL of gene
expression master mix; and the Phagocytosis Array was processed
in a 20 mL reaction volume containing 5 ng of cDNA, 10 mL
water and 10 mL Gene Expression Master Mix. Amplification
reactions were performed with 7900HT Fast Real Time (Applied
Biosystems) using the following conditions: 95uC for 20 min, and
40 cycles of 95uC for 1 s and 60uC for 20 sec. Expression levels of
all transcripts studied were normalized to the GAPDH level and
the relative changes in gene expression generated between 12 SS
patients and three healthy controls were calculated with the
22DDCt method using DataAssistTM v2.0 Software (Applied
Biosystems). Up- or down-regulation of gene transcripts for this
analysis were considered significant if their expression pattern in
tissue was at least 2-fold higher or lower than control skin-samples
and if the p-value was ,0.05. Selected gene transcripts were
confirmed by conventional RT-PCR as described above.
Immunohistochemistry (IHC)
Paraffin embedded skin biopsies which were available from 4/
12 patients studied by microarray (see above), were immunohis-
tochemically labeled with antibodies against CD4, CD8, CD56,
CD11c, CD14 and CD68 using an automated IHC staining
platform (Bond Max, Leica-Microsystems, Buffalo Grove, IL).
IHC staining for Tp was manually performed at room tempera-
ture. Slides sections were depparaffinized in xylene (Allegiance
Healthcare Corporation, McGaw Park, IL) and rehydrated in
graded alcohol to water. After quenching endogenous peroxidase
activity and a wash in phosphate-buffered saline (PBS), the slides
were incubated for 30 minutes at room temperature with a rabbit
polyclonal anti-Tp antibody (dilution 1:500; Biocare, Concord,
CA). Following a short wash in PBS, slides were covered with anti-
rabbit EnVision+ detection system (Dako, Carpinteria, CA) for
30 minutes. Following a final wash in PBS, slides were incubated
with the AEC+ (aminoethylcarbazole) chromogen (Dako) for
10 minutes, rinsed and counterstained in hematoxylin. Positive
and negative controls were run in parallel for each of the
antibodies used. For evaluation of immunofluorescence results
biopsy specimens were read in a blinded fashion by at least one
independent investigator. Labeled cells were enumerated per
visual field and expressed as a percentage of inflammatory cells per
200 cells counted per high power field (HPF).
Statistical Analysis
Immunologic markers of interest were first compared between a
group of healthy controls affiliated by employment to the CIDEIM
facility and healthy controls of similar socio-economic background to
SS patients enrolled in the study. Student t test or the equivalent non-
parametric methods (i.e. Mann-Whitney U) test results allowed us to
conclude that immunologic parameters of interest between the two
healthy control populations were not statistically different (data not
shown). Results from the combined control group were thus used for
all comparisons between healthy volunteers and SS patients. Flow
cytometry cell surface expression patterns of immunologic markers
of interest and cytokine outputs were compared between patients
and controls by using unpaired Student t tests or where indicated the
equivalent non-parametric test (i.e. Wilcoxon). A two-tail statistical
analysis was performed for all comparisons, except to analyze dose-
responses in the Tp-monocyte stimulation assay results. For each
analysis, both the standard deviation and the standard error of the
mean (SEM) were calculated and p values of,0.05 were considered
significant. Statistical analysis was done using GraphPad prism 4.0
(GraphPad Software, San Diego, CA).
Results
Immunophenotypic Alterations in Peripheral Blood
Monocyte (PBMC) and dendritic Cells (DCs) in Untreated
SS Patients
We recently reported that a significant proportion of a cohort of
untreated SS patients had low-level spirochetemia based on whole
blood Tp-DNA quantitation [8]. This finding, together with our
earlier demonstration that HSS induces opsonophagocytosis-
dependent activation of monocytes and DCs in PBMCs [28],
prompted us to examine whether circulating monocytes and DCs
obtained from these same SS patients exhibited evidence of
immune activation at the time of initial presentation. Unlike
healthy volunteers, at study entry more than half (7/13) of the
patients studied exhibited increases in the size and granularity in
the total monocyte population, which were no longer present two
months after penicillin treatment (Figure 1). Expression of the
activation marker CD40 and mean fluorescence average values for
CD14 (Figure 2) also were increased in monocytes from
untreated SS patients; statistically significant post-treatment
reductions confirmed that this finding was disease-specific. Despite
these immunophenotypic alterations, there were no significant
pre-treatment increases in selected cytokines (TNF, IL-1b, IL-10
or IL-6) based on either qRT-PCR analysis of isolated PBMCs or
CBA of pre-treatment sera (data not shown). We also studied
circulating DCs, using expression of CD11c [46,47] to distinguish
monocytoid (CD11c+) and plasmacytoid (CD11c2) DCs. As
depicted in the representative flow cytometry dot plots in
Figure 3, 67% (10/15) of the patients studied exhibited a
selective decrease in the proportion of CD11c+ DCs (,35%),
Innate and Adaptive Immunity in Secondary Syphilis
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which corrected in all but three patients at the follow-up visit.
Neither DC population displayed increased expression of the
activation marker CD83 (Figure 3).
Emergence of a CD56negative NK-cell Population in SS
Patients
NK-cells play a critical role in the immune response to human
pathogens by secreting IFN-c and other immunomodulatory
molecules [48,49] and by promoting T-cell polarization and DC
maturation [50]. The finding that NK-cells are the principal
source of IFN-c in Tp-stimulated PBMCs [28], together with
existing evidence that total NK-cell numbers and function may be
altered during SS [51,52], prompted us to study circulating NK-
cell subsets in the blood of our patients. NK-cells were classified by
flow cytometry using a previously described scheme according to
their relative expression of CD16 and CD56, (Figure 4A) [53,54].
CD56bright cells are known to be potent cytokine producers with
limited cytotoxic activity, while CD56dim cells have strong
cytotoxic capacity but a decreased ability to produce cytokines
[53,54]. As displayed in Figure 4B–C, when compared to healthy
controls, a significantly greater percentage of SS patients had total
circulating NK-cell values below the 5th percentile of published
normal adult NK-cell numbers [55] (40% vs. 4.3% respectively,
p = 0.01). Significant decreases in IFN-c-producing (CD56bright)
and cytotoxic (CD56dimCD16bright) NK-cell subsets were largely
responsible for the decline in total NK-cell values (Figure 5). By
contrast the CD56negativeCD16bright NK-cell subset, a recently
described NK-cell population which exhibits both poor cytolytic
activity and impaired cytokine production [41], was significantly
increased in most untreated SS patients (Figure 6) but returned to
near normal values in all patients at the follow-up visit.
Substantial Numbers of Spirochetes Co-Exist within a
Mixed Cellular Infiltrate in Skin Lesions from SS Patients
We previously reported [8] that the routine histology for the
patients described in this study was characteristic of typical SS
Figure 1. Secondary syphilis induces immunophenotypic alterations in human monocytes. Peripheral blood mononuclear cells (PBMCs)
were isolated from secondary syphilis (SS) patients before and around 60 days after penicillin treatment and compared to healthy controls. The flow
cytometry dot-plot reveals forward and side scatter features of gated monocytes from three different and representative patient samples. The dot
plots reveal a population of monocytes with increased size and granularity in SS patients, which normalized at the follow-up visit.
doi:10.1371/journal.pntd.0001717.g001
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lesions [2,5,32,33,56,57]. Herein, we used IHC staining tech-
niques to analyze four SS skin biopsies and corroborate that the
cellular infiltrates were in agreement with previously published
IHC analysis [32,38,56,58] and to explore potential mechanisms
for immune recognition of spirochetes within tissues. Substantial
numbers of dermal mononuclear cells expressed the macrophage
marker CD68 (Table S3 and Figure 7A and B) [59]. Staining
with two other macrophage markers (CD11c and CD14)
revealed very similar patterns (data not shown). Syphilitic lesions
were also comprised of CD4+ and CD8+ lymphocytes
(Figure 7B–E), with the CD8+ phenotype predominating in
three of the four biopsies [36] (Table S1). Interestingly, 5% of
dermal mononuclear cells expressed the NK-cell marker CD56+,
an approximate five-fold increase from normal percentages
(,1%) of NK-cell values in healthy skin [48] (Figure 7F and G
and Table S1). Because of the lack of specific markers for
CD56negativeCD16high NK-cells, we were unable to determine if
this unexpected circulating NK-cell phenotype was also present
in the skin of SS patients. Several recent studies have also called
attention to the sensitivity of IHC for detection of spirochetes in
tissues in addition to its well-recognized ability to provide
information regarding the spatial relations between Tp and
cellular infiltrates in the skin [2,5,32,33,57]. In agreement with
these prior reports, dense clusters of spirochetes could be seen in
Figure 2. Cell surface activation markers in secondary syphilis patient monocytes. Cell surface activation markers were examined in
monocytes from secondary syphilis (SS) patients before (Pre-Tx) and around 60 days after penicillin treatment (Post-Tx) and compared to healthy
controls. (A) A modest but significant decrease in CD40 MFI was evident between paired acute and convalescent samples obtained from SS patients
before and after treatment. (B) Significant increases in CD14 MFI expression were observed between syphilis patients and healthy volunteers prior to
antibiotic treatment and between pre- and post-penicillin treatment (p values are shown in the figure).
doi:10.1371/journal.pntd.0001717.g002
Figure 3. Immunophenotypic alterations in dendritic cell (DC) populations. Circulating DCs were analyzed by flow cytometry in secondary
syphilis (SS) patients before (Pre-Tx) and after penicillin treatment (Post-Tx). DCs were characterized by flow cytometry parameters as being HLA-DR+
and Lineage cocktail negative (not shown) and the expression of CD11c into monocytoid (CD11c+) and plasmacytoid (CD11c2) and expression of the
co-stimulatory molecule CD83. A marked decrease was observed in the CD11c+ population in the blood of 7/12 SS patients and at the follow-up visit
this population recovered in these same SS patients.
doi:10.1371/journal.pntd.0001717.g003
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a perivascular location within the papillary dermis in close
physical proximity to aggregates of lymphocytes and histiocytes
(Figure 8). Spirochetes were also visualized in the mid- and
deep-layers of the dermis away from infiltrating cells, straddling
the dermal-epidermal interface, and within the lower layers of
the epidermis (data not shown). Lastly, we confirmed that all four
biopsies studied had Tp DNA by quantitative PCR analyses
(Table S1).
Microarray Analysis of Cutaneous Lesions
Transcriptional analysis of SS skin biopsies has thus far been
limited to a small number of gene products [32,38]. In this study,
we used transcriptional profiling to gain additional insights into the
molecular mechanisms underlying the inflammatory responses
elicited by spirochetes in skin. Table 3 highlights key transcripts
associated with the array, while the complete list is presented in
Tables S2 and S3. Consistent with the finding by IHC that
Figure 4. Secondary syphilis (SS) patients exhibit a significant decrease in total NK-cell populations. (A) Gating procedure to determine
NK-cells subsets according to CD56 and CD16 expression by flow cytometry are shown. (B and C) A significantly larger percentage of SS subjects
exhibit NK-cell values below the 5th percentile of established published normal values (line depicts the cutoff), when compared to healthy controls
(* indicates p,0.05).
doi:10.1371/journal.pntd.0001717.g004
Figure 5. NK-cell subsets distribution in secondary syphilis (SS) patients. SS patients exhibit significant decreases in (A) cytokine-producing
NK-cells (* p=0.02) and (B) cytotoxic NK-cells (* p,0.001). Values are shown at enrollment (Pre-Tx) and after penicillin treatment (Post-Tx). Neither cell
subset appears to recover following treatment.
doi:10.1371/journal.pntd.0001717.g005
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syphilitic lesions contain an abundance of macrophages, the
transcript for CD68 [59] was significantly up-regulated. Also
upregulated were transcripts for the macrophage activation
markers CD40 [60], CD80 and CD86 [61], a number of cytokines
known to be secreted by human monocytes/macrophages in
response to opsonized Tp (TNFa, IL-6, IL-1b and IL-10), and
numerous other molecules associated with macrophage activation.
Interestingly, transcripts for both TLR1 and TLR2, which are
required for recognition of treponemal lipoproteins by monocytes/
macrophages [28], were up-regulated, whereas TLR6, which
recognizes diacylated lipoproteins in association with TLR1 [62],
was not. Transcripts for three different FCc phagocytic receptors,
Figure 6. Emergence of a CD56-negative NK-cell population in secondary syphilis (SS) patients. (A) The CD56negative CD16+ NK-cells
subset in untreated SS patients are shown by the black arrows. (B) Significant increases (* p=0.003) in CD56 negative CD16+ NK-cell population was
seen in SS patients. This anomaly was not present in healthy controls.
doi:10.1371/journal.pntd.0001717.g006
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FCcR1A/C (CD64), FCcR2A (CD32), and FCcR3A/B (CD16)
also were significantly over-expressed in lesional skin.
Transcripts for the T-cell receptors CD3, CD4 and CD8, as
well as the T-cell activation marker CD38, were all markedly
increased in lesional biopsies (Table 3). IFNc, a potent
macrophage activator that can be produced by CD4+ and
CD8+ memory T-cells as well as NK-cells, also was significantly
up-regulated in lesional biopsies. The transcript for IL-17 also was
expressed in the lesional biopsies, which is in agreement with a
recent report that IL-17+ T-cells are present in the skin of SS
patients [38]. Of particular interest, we saw a dramatic increase in
expression of transcripts for granulysin, perforin and granzyme B,
which can be produced by both NK-cells [63] and CD8+ T-cells
[64], thus, providing evidence for a strong cytotoxic response.
Type I IFNs modulate multiple aspects of innate and adaptive
immunity in response to bacterial infections [23,65,66], including
Figure 7. Immunophenotypic cellular composition of the inflammatory infiltrate in secondary syphilis patient skin lesions. IHC
staining depicts CD68+macrophages (A and B), CD4+ T-cells (C and D), CD8+ T-cells (E and F) and CD56+ NK-cells (G and H). Panels B, D, E and H are
high magnification images of the red boxed areas in A, C, E and G.
doi:10.1371/journal.pntd.0001717.g007
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activation of NK-cells, DCs and macrophages. The arrays
revealed marked increases in the expression of three endosomal
TLRs, TLR-7, TLR-8 and TLR-9 [67], all of which are associated
with the production of type I IFNs [65,68]. TLR7 and TLR9 are
expressed predominantly by plasmacytoid DCs, a subset which we
previously have shown is enriched in SS skin lesions [69], whereas
TLR8 is expressed by activated human macrophages [70]. Two
type I IFN-inducible chemokines, CXCL10 (IP-10) and CXCL11
(IP-9), were significantly over-expressed in lesional biopsies. In line
with these results, we found by RT-PCR that the transcript for
IFN-b was also up-regulated in lesional biopsies (data not shown).
Human Syphilitic Serum (HSS) Promotes
Opsonophagocytosis of Treponemes and Monocyte
Activation
Syphilitic antibodies are believed to play an essential role in
both cellular activation and bacterial clearance by promoting
opsonophagocytosis of the syphilis spirochete by macrophages
[40,57,71,72]. Herein, we used an ex vivo stimulation assay to
model the effect of opsonic antibodies on spirochete-monocyte/
macrophage interactions at graded MOIs as it may occur in the
skin and blood of patients. In comparison to normal human sera,
pooled syphilitic sera significantly enhanced monocyte uptake of
Tp in a dose-dependent manner (Figure 9A). Similar results were
obtained for serum specimens of 12 different patients confirming
that opsonic antibodies are commonly produced in early syphilis
(data not shown). Interestingly, even in the presence of HSS a
large proportion (56%) of the spirochetes was not phagocytosed
(Figure 9B). The observation that the percentage of spirochetes
recovered was not significantly different between the MOIs of 1,
10 and 30 (Figure 9C), argues that the lack of uptake at the
higher MOI is not due to FC-receptor saturation. As shown in
Figure 10, opsonized Tp also induced a marked dose-dependent
increase in secretion of TNF and IL-1b. Importantly, cytokine
production was minimal at the lowest MOI (1:1) tested, which is
similar to the MOI in spirochetemic SS patients (Table 1). A
similar dose-dependent increase was seen in the production of Il-6
and IL-10 and expression of the activation markers CD40 and
CD83 (data not shown).
Discussion
Venereal syphilis can be considered a contest between the
ability of T. pallidum to avoid immune recognition and the
adeptness of the host’s innate and adaptive immune responses to
‘‘track down’’ and eliminate the spirochetal pathogen. To begin to
understand the mechanisms that underlie the dichotomy between
immune evasion and immune recognition of the syphilis bacteri-
um, herein we compared key aspects of the innate and adaptive
immune response in the blood and skin of SS patients, to
spirochetal burdens present in these two immunologically distinct
compartments. The evidence suggests that spirochetes circulate
through the blood mostly unimpeded by host’s immune defenses,
while the larger burden of treponemes present in the skin elicit a
highly complex inflammatory cellular immune response that
paradoxically does not rapidly control spirochetal replication.
Our results reinforce the importance of the macrophage in the
immune response to Tp and establish that the balance between
phagocytic uptake of the spirochete and its ability to evade innate
immune recognition is influenced by the number of bacteria
present in either the blood or the skin, as well as the emergence of
Tp-subpopulations with differential capacities for binding opsonic
antibodies. We hypothesize that the striking immunophenotypic
alterations found in circulating innate immune cells in SS patients
are not the result of their direct interaction with spirochetes in the
Figure 8. Spirochetal clusters are present in secondary syphilis skin lesions. Representative skin biopsy from a posterior neck secondary
syphilis (SS) lesion was processed for IHC. (A/B) H&E stain of SS lesions. (C/D) IHC staining reveals abundant spirochetes embedded within a mixed
cellular inflammatory infiltrate (shown in the red box) in the papillary dermis. The blue arrow points to a tissue histiocyte and the read arrows to two
dermal lymphocytes.
doi:10.1371/journal.pntd.0001717.g008
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Table 3. Transcriptional Profile - Secondary syphilis skin biopsies (n = 12) vs healthy control skin (n = 3).
Gene Transcript Name Fold Increase p value
PATHOGEN RECOGNITION
Macrophage and Dendritic Cell Activation
CD40 CD40 2 ,0.05
CD80 B7-1 129 ,0.05
CD86 B7-2 6 ,0.05
Fc c Receptors
FcGR1A/FcGR1C CD64 84 ,0.01
FcGR2A CD32 7 ,0.01
FcGR3A/FcGR3B CD16 21 ,0.01
Toll-like receptors
TLR1 Toll-Like-Receptor 1 6 ,0.01
TLR2 Toll-Like-Receptor 2 2 ,0.05
TLR7 Toll-Like-Receptor 7 19 ,0.01
TLR8 Toll-Like-Receptor 8 22 ,0.01
TLR9 Toll-Like-Receptor 9 19 ,0.01
Scavenger Receptors
CD68 Scavenger Receptor Class D 12 ,0.01
CYTOKINES and GROWTH FACTORS
TNF Tumor Necrosis Factor 9 ,0.01
IL6 Interleukin 6 9 ,0.01
IL1B Interleukin 1b 17 ,0.01
IL10 Interleukin 10 27 ,0.01
IFNG Interferon c 6 ,0.05
IL-15 Interleukin 15 13 ,0.05
IL17 Interleukin 17 2 ,0.05
IL2RA CD25, Interleukin 2 receptor A 8 ,0.05
IL4 Interleukin 4 35 .0.05
TGFB1 Transforming Growth Factor 3 ,0.01
CHEMOKINES
CCL2 MCP-1, Macrophage inflammatory protein-1 7 ,0.01
CCL3 MIP-1a, Macrophage inflammatory protein-1a 115 ,0.05
CCL5 RANTES, Regulated upon Activation, Normal T-cell
Expressed, and Secreted
63 ,0.01
CCL19 MIP-3b, Macrophage inflammatory protein-3b, SLC 8 ,0.05
CXCL10 IP-10, IFNc induced protein 10kDa, CRG-2 387 ,0.01
CXCL11 IP-9, IFNc induced protein 9, I-TAC 226 ,0.01
CCR4 C-C chemokine receptor type 4, CD194 3 ,0.05
CCR5 C-C chemokine receptor type 5, CD195 10 ,0.01
CCR7 C-C chemokine receptor type 7, CD197 18 ,0.01
LYMPHOCYTES
CD3E CD3 13 ,0.01
CD8A CD8 177 ,0.01
CD4 CD4 7 ,0.01
CD19 CD19 27 ,0.05
CD28 CD28 9 ,0.01
CD38 CD38 52 ,0.01
CYTOLYTIC ACTIVITY
GNLY Granulysin 85 ,0.01
GZMB Granzyme B 78 ,0.01
PRF1 Perforin 18 ,0.01
doi:10.1371/journal.pntd.0001717.t003
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blood, but instead a manifestation of the systemic effects of the
bacterium in other tissues including the bone marrow. Lastly, we
demonstrate that in addition to CD4+ and CD8+ T-cells, CD56+
NK-cells are enriched in Tp-infected skin lesions and, thus, could
contribute to macrophage activation and bacterial clearance
through their ability to secrete IFN-c.
One of the most significant findings in this study is the extent of
the immunophenotypic alterations that distinguish monocytes,
DCs and NK-cells in the blood of untreated SS patients from those
of healthy controls. Despite the demonstration that circulating
monocytes were noticeably larger by flow cytometry and expressed
higher levels of CD14 and CD40 than monocytes obtained from
healthy volunteers, SS patients did not have measurable increases
in transcription or secretion of monocyte-derived cytokines in their
blood. The ex vivo finding that bacterial uptake and cytokine
production was minimal at low spirochete-monocyte ratios (1:1),
Figure 9. T. pallidum (Tp) uptake and recovery by IFA. Purified human monocytes obtained from healthy controls were stimulated with fresh Tp
Nichols strain (MOI 1:1, 10:1 and 30:1) were incubated for 8-hours alone or where indicated in the presence of 10% heat inactivated normal human
serum (NHS) or human syphilitic serum (HSS). (A) Percentage of phagocytosed Tp was greater when HSS was present. (B) Percentage of non-
phagocytosed Tp which were recovered in supernatants at the end of incubation time is shown in each of the two graphs. Spirochetal recovery was
substantially higher in the absence of HSS; nonetheless more than half of the bacteria avoided recognition and uptake despite the presence of HSS (p
values shown correspond to statistical comparisons between groups by ANOVA). (C) Percentage of spirochetes recovered was similar in the presence
of HSS at three different MOIs.
doi:10.1371/journal.pntd.0001717.g009
Figure 10. Cytokine output in response to opsonized Tp. Isolated human monocytes were stimulated for 8-hours with live Tp at three different
spirochete to monocyte ratios (MOIs) (1:1, 10:1 and 30:1) in the presence or absence of 10% heat inactivated human syphilitic serum (HSS). LPS was
used as a positive control. Cytokines in supernatants were quantitated in picograms (pg)/ml by cytokine bead array as described in Methods. A, C:
Higher cytokine production (TNFa and IL-1b) was elicited when spirochete-stimulated monocytes were immersed in 10% heat inactivated HSS. B, D:
Cytokine output was greater with higher MOIs (* indicates where p values are ,0.05 between different conditions studied by paired or unpaired
student’s T-test analysis as described in the Methods, NS = non-significant differences).
doi:10.1371/journal.pntd.0001717.g010
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an MOI that closely mirrors the calculated MOI in the blood of
SS patients, may explain why low levels of spirochetes in the blood
are unable to induce cytokine production by circulating mono-
cytes. Given that similar morphologic changes were not evident ex
vivo Tp-stimulated monocytes at a similar spirochete to cell ratio of
1:1 (data not shown), leads us to conclude that the immunophe-
notypic alterations in circulating monocytes could be provoked
directly by the spirochete in the blood. Instead they raise the
possibility that the syphilis spirochete could be affecting macro-
phage-DC progenitor cells in the bone marrow, before they
differentiate into CD14+ monocytes and mobilize into the blood
stream [73]. The striking decrease in circulating CD11c+ DCs
suggests that these cells are marshaled from the blood into infected
skin tissues [74]. Our prior findings that monocytoid DCs
obtained from the blood and skin of SS patients express high
levels of the C-type lectin DC-SIGN [43], an adhesion molecule
which is known to regulate DC trafficking from blood into tissues
[75], supports the notion that this DC subset migrates into infected
skin. A particularly novel finding in this study was the marked
decrease in total circulating NK-cell numbers and the distinct
emergence of a highly atypical circulating CD56negativeCD16bright
NK-cell population. Mavilio and colleagues [41,42] previously
reported similar increases in HIV-infected patients with uncon-
trolled viremia and confirmed that this subset of NK-cells was not
only poorly cytolytic but also had an impaired capacity to produce
IFN-c and other cytokines. Our report is the first to show that this
abnormal NK-cell subset can also be increased in the course of a
bacterial infection.
The critical role of the macrophage in the pathogenesis of
venereal syphilis was initially ascertained from histological analysis
of Tp-infected rabbit tissues [76,77] and the finding that rabbit
immune sera markedly enhanced spirochetal uptake and clearance
by peritoneal macrophages in vitro [71]. Results from prior human
studies are generally in line with those in the rabbit model in that
they confirm that large numbers of macrophages and T-cells are
also present in early syphilis lesions [36,37,56,78–80]. Herein, we
used a combination of IHC and transcriptional profiling to
corroborate that macrophages are indeed the predominant
inflammatory cell in the skin. The confirmation that HSS
enhances uptake of spirochetes by isolated monocytes ex vivo,
inducing their activation in a dose-dependent manner, under-
scores the importance of opsonophagocytosis in spirochetal
recognition and clearance. While low-level spirochetemia seem-
ingly facilitates chronic spread of the bacterium, in Tp-rich skin
infiltrates opsonized spirochetes are more likely to be taken up by
IFN-c activated tissue macrophages. Paradoxically, the ex vivo
model results also indicate that even at high MOIs, a large subset
of the spirochetes avoid phagocytosis by monocytes. This finding is
in accord with the observation in the rabbit model by Lukehart
and co-workers [27] that a subpopulation of opsonic antibody-
resistant spirochetes emerges during active infection. The same
group has proposed that antigenic variation in candidate OMP
antigenic targets (i.e. TprK) helps us understant how Tp evades
host antibody responses [81]. Our own data suggests that an
additional explanation is that Tp populations differ widely with
respect to the density of surface antigens recognized by syphilitic
serum [25], which would then allow populations of spirochetes to
escape opsonization and avoid clearance.
The role of the adaptive cellular immune response in
treponemal clearance has been studied in the rabbit model and
in humans with active disease [2]. Replication of treponemes at
the site of inoculation in rabbit tissues elicits an intense
inflammatory response that histologically resembles a classic
delayed type hypersensitivity reaction (DTH) [56], which in
addition to macrophages is composed predominantly of CD4+
lymphocytes [34]. IHC and molecular studies in humans confirm
that primary and SS lesions are also enriched for Th1-cytokine
producing CD4+ lymphocytes [32,33]. In contrast to the rabbit,
however, and in support of the findings in this study, CD8+ T-cells
are often the predominant T-cell immunophenotype in SS lesions
[37,38,78]. Our prior demonstration that CD4+ and CD8+ T-
cells in blister fluid elicited over SS lesions are predominantly of
the memory and memory effector immunophenotype, expressing
the activation marker CD38 [43], can be interpreted as an
indication that populations of T-cell subsets in the skin of patients
are antigen-specific. While naı¨ve CD4+ T-cells are primed in the
lymph-nodes by treponemal antigens via MHC-class II pathways
[82], CD8+ T-cells will require some form of cross-presentation of
spirochetal peptides via MHC-class I molecules [82,83]. One
plausible explanation for how cross-presentation might occur is
that treponemal constituents enter alternative endocytic pathways
in DCs or macrophages, allowing bacterial peptides to bind to
MHC-class I molecules in the endoplasmic reticulum [82]. It is
interesting to note, in this regard, that Bouis et al. [84] showed that
DCs ingest virulent treponemes by coiling phagocytosis, an uptake
mechanism that has been associated with cross-presentation [85].
An additional reason for this phenomenon is that circulating
spirochetes could be internalized and cross-presented directly by
lymph node-resident DCs; a highly specialized DC population
which in humans can cross-present antigen without activation
[86]. Because NK-cells promote the development of adaptive
immunity via a bi-directional cross-talk between naı¨ve CD4+ T-
cells and DCs [42,53], one could envision a model where
alterations in circulating NK-cell populations, as shown herein,
could interfere with adequate antigen presentation to CD4+ T-
cells in the lymph nodes. Cross-priming of naı¨ve CD8+ T-cells in
SS could, thus, serve as a compensatory mechanism for less than
optimal CD4+ T-cell priming in the lymph nodes of SS patients.
How CD8+ T cells are activated in the skin is not entirely clear
since this subset typically responds to intracellular bacterial
pathogens [87,88]. Perhaps CD8+ T-cells are required to
eliminate intracellular reservoirs of the bacterium that may be
present in non-phagocytic cells from early syphilis lesions [89–91].
Then again, treponemal antigens could be cross-presented to
cytolytic T-cells in the skin by tissue based macrophages and/or
DCs inducing their activation. Given that cytokine producing
CD56+ NK-cells were also enriched in the skin of patients, it is
also plausible that this innate immune lymphocyte provides an
additional source of IFN-c in Tp-infected tissues. In support of this
idea, we previously demonstrated that in Tp-stimulated PBMCs,
NK-cells are a major source of IFN-c [53] and showed that
production of this cytokine is dependent on the presence of
accessory cells (i.e., DCs). Lastly, in agreement with a recent report
that IFN-c and IL-17 producing CD8+ T-cells are present in the
skin of SS patients [38], the transcript for IL-17 also was up-
regulated in SS biopsies [38]. It is conceivable that IL-17
producing T-cells play an important compensatory role in SS,
particularly in HIV-syphilis co-infected patients with very low
CD4+ T-cell counts.
Although type I IFNs have generally been associated with
antiviral immune responses, there is now compelling evidence that
these cytokines also are induced in response to several intracellular
[68,92–95] and extracellular bacteria [23,96,97]. It was, therefore,
not at all surprising that IFN-b and several type I IFN associated
transcripts (Table 3) were up regulated in SS lesions. A variety of
ligands, including bacterial DNA and RNA, can activate PRRs
present in either the cell cytosol or membrane bound TLRs [68] to
induce type I IFNs. In this regard, we recently provided evidence
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that transcription of IFN-b in human monocytes stimulated ex vivo
with Borrelia burgdorferi, the Lyme disease spirochete, was dependent
on phagocytosis and degradation of the bacterium and required
signaling through TLR8 [23]. In support of a similar role for
phagosomal signaling in Tp-mediated induction of type I INFs,
three endosomal TLRs (TLR7, 8 and 9), capable of sensing nucleic
acids within phagosomes of macrophages and DCs [98–100], also
were markedly up-regulated in syphilis lesions. Type I IFNs are
likely to have several important roles in the immune response to the
spirochete. Firstly, type I IFNs can induce the differentiation of
plasmacytoid DCs into mature antigen presenting DCs through
their ability to up-regulate surface expression of co-stimulatory
molecules like CD80, CD86, and CD40 [68]. Type I IFNs could
also help regulate NK-cell function by inducing the production of
IL-15 by macrophages, a cytokine which was increased in SS lesions
and can promote NK-cell survival and proliferation [101]. Lastly,
type I IFNs may facilitate cross-presentation of antigens via MHC
class I molecules to CD8+ T-cells [65].
Based upon the findings from this and prior studies [43], we
now propose a revised early syphilis pathogenesis model that
integrates innate and adaptive immune responses to the bacterium
and also takes into account the spirochete’s immunoevasive
countermeasures against host defenses. According to this model,
spirochetes replicate at the site of initial inoculation unchecked by
the innate immune surveillance system and rapidly disseminate to
the skin and other tissues. At some point after initial entry of the
bacterium increasing local spirochetal burdens allow a small
number of organisms to be taken up by resident phagocytes,
although this process is inefficient in the absence of opsonic
antibodies. APCs containing phagocytosed spirochetes can then
migrate into draining lymph nodes where they present treponemal
antigens to naı¨ve CD4+ T cells and B-cells. We postulate that neo-
sensitized T-helper cells traffic back into the primary lesion, where
they recognize their cognate antigens and release IFN-c.
Clearance of organisms by IFN-c activated tissue macrophages
is markedly facilitated by the emergence of high titers of Tp-
specific opsonic antibodies. In parallel events, while the chancre
resolves, as soon as treponemal loads in the skin of early syphilis
patients reach a sufficient density capable of triggering the local
inflammatory response, SS skin lesions become clinically apparent.
In contrast to the immunologic events that initially take place in
the primary chancres, innate and adaptive immune responses in
SS skin lesions appear to co-evolve in the presence of both
memory and memory effector CD4+ and CD8+ T cells and high
titers of opsonic antibodies. One would thus predict that these
changes would be sufficient for the immune response to eradicate
the bacterium. However, the paucity of OMP antigenic targets on
the outer leaflet of the bacterium together with the emergence of
Tp-subpopulations resistant to opsonophagocytosis, permits vary-
ing numbers of bacteria to avoid opsonization, uptake and
clearance by dermal macrophages. The low-level bacteremia
which ensues allows the spirochete to avoid recognition by host
innate and adaptive immune defenses in the blood compartment.
The constant spread of Tp into other tissues during SS, specifically
the bone marrow, could affect the development of myeloid and
lymphoid progenitors of monocytes/macrophages, DCs and NK-
cells. Fortunately for the host, over time, the emergence of greater
numbers of activated memory and memory effector CD4+ and
CD8+ T-cells, IFN-c producing CD56+ NK-cells together with
increasing titers of Tp-specific opsonic antibodies, allows the host
to ultimately gain the upper hand against the bacterium. The
complex shifting balance between immune evasion and bacterial
persistence to immune recognition and spirochetal clearance, will
thus, not only determine the intensity and duration of the clinical
manifestations of venereal syphilis but also how long the spirochete
can endure in blood and tissues.
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